CVS Health Reports Second Quarter Results; Diversified Assets Deliver Strong Enterprise Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
CVS Health (CVS) Tops Q2 EPS by 72c, Offers FY Guidance
August 5, 2020 6:35 AM EDTCVS Health (NYSE: CVS) reported Q2 EPS of $2.64, $0.72 better than the analyst estimate of $1.92. Revenue for the quarter came in at $65.3 billion versus the consensus estimate of $64.18 billion.
GUIDANCE:
CVS Health sees FY2020 EPS of $7.14-$7.27, versus the consensus of... More



